Physician profile
Sandra Zawadka
NPI 1164050704
$3,116.74
in general payments reported to CMS, 2019-2025
13 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,113 · 2024: $660 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,459 · Travel and Lodging: $658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,458.65 |
| Travel and Lodging | $658.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $907.14 | 2023-2024 | Prostep, Hoffmann, Variax |
| Integra Lifesciences Corporation | $794.85 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $545.60 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Tactile Systems Technology INC | $295.26 | 2024 | Flexitouch Plus, Entre Plus |
| Smith+Nephew, INC. | $206.18 | 2023-2025 | Grafix Pl, Collagenase Santyl, Grafix |
| Treace Medical Concepts, INC. | $193.31 | 2024 | |
| Ani Pharmaceuticals, INC. | $47.75 | 2025 | Purified Cortrophin Gel |
| Bioventus LLC | $29.46 | 2024 | Exogen Ultrasound Bone Healing System |
| Lifenet Health | $23.37 | 2023 | |
| Averitas Pharma INC. | $22.92 | 2024 | Qutenza |
| Paratek Pharmaceuticals, INC. | $18.21 | 2024 | Nuzyra |
| Musculoskeletal Transplant Foundation INC. | $17.57 | 2023 | |
| Solventum Corporation | $15.12 | 2024 | Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Zawadka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.